Analysts Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) PT at $9.93

Posted by Defense World Staff on Apr 26th, 2025 Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Free Report) has received an average recommendation of “Hold” from the seven research firms that are presently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $9.93. A number of research analysts have recently commented on the company. Truist Financial dropped their price target on Treace Medical Concepts from $9.50 to $8.00 and set a “hold” rating on the stock in a research report on Friday, April 11th. Lake Street Capital started coverage on shares of Treace Medical Concepts in a research report on Tuesday, December 31st. They set a “buy” rating and a $14.50 target price for the company. Finally, BTIG Research raised shares of Treace Medical Concepts from a “neutral” ratin...